Track topics on Twitter Track topics that are important to you
Biomira Inc. (TSE: BRA; Nasdaq: BIOM) is a product focused biotechnology company applying its proprietary immunotherapy and organic chemistry technologies for the development of cancer therapeutics. The Company's lead product, THERATOPEÂ® vaccine, is currently being tested in a Phase III clinical trial for metastatic breast cancer. The Company's commitment to the development of products for the treatment of cancer is focused on synthetic therapeutic vaccines and innovative strategies for immunotherapeutic treatment of cancer. The vision at Biomira is clear and simple-we intend to build a profitable company based on the discovery and development of vaccines and related immunotherapeutic products for the treatment of cancer. We are The Cancer Vaccine PeopleTM.
Phone: (780) 450-3761
Fax: (780) 463-0871
Biomira Inc. (TSE: BRA; Nasdaq: BIOM) is a product focused biotechnology company applying its proprietary immunotherapy and organic chemistry technologies for the development of cancer therapeutics. T...
We have published hundreds of Biomira news stories on BioPortfolio along with dozens of Biomira Clinical Trials and PubMed Articles about Biomira for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biomira Companies in our database. You can also find out about relevant Biomira Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...